Charterhouse sells Italian pharma company to CVC

The deal is understood to be in the range of €650 to €700 million and is slated to close in mid-2016.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this